Full Press Release Details
SAN FRANCISCO , March 22, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) management is scheduled to present at the upcoming H.C. Wainwright 2 nd Annual Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 28, 2024 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time .
The presentation and Q&A session will be accessible via a webcast through a link posted on the Investor Events section of the Nektar website: https://ir.nektar.com/events-and-presentations/events . This webcast will be available for replay until April 28, 2024 .
About Nektar Therapeutics
Vivian Wu of Nektar Therapeutics 628-895-0661
David Rosen of Argot Partners (212) 600-1902 [email protected]
SOURCE Nektar Therapeutics